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Although CaV1.2 and CaV1.3 are two subtypes of L-type Ca2+ channels expressed in the CNS, functions
of CaV1.3 have not been well elucidated compared to CaV1.2. Here, we found that CaV1.3-NT associ-
ates with GABABR2-CT using yeast two-hybrid, GST pull-down and co-immunoprecipitation assays.
We also demonstrated co-localization of CaV1.3 and GABABR2 in HEK293 cells and cultured hippo-
campal neurons. Whole-cell patch-clamp and Ca2+-imaging experiments revealed that activation
of GABABR increases CaV1.3 currents and intracellular Ca2+ via CaV1.3, but not CaV1.2. These results
show a physical and functional interaction between CaV1.3 and GABABR, suggesting the potential
pivotal roles of CaV1.3 in the CNS.
Structured summary:
MINT-7975667: Cav1.3 (uniprotkb:P27732) physically interacts (MI:0915) with GABABR2 (uni-
protkb:O88871) by two hybrid (MI:0018)
MINT-7975740: Cav1.3 (uniprotkb:P27732) and GABABR2 (uniprotkb:O75899) colocalize (MI:0403) by
ﬂuorescence microscopy (MI:0416)
MINT-7966007, MINT-7966016: Cav1.3 (uniprotkb:P27732) physically interacts (MI:0915) with GABABR2
(uniprotkb:O88871) by anti bait coimmunoprecipitation (MI:0006)
MINT-7975712, MINT-7975691: Cav1.3 (uniprotkb:P27732) physically interacts (MI:0915) with GABABR2
(uniprotkb:O88871) by pull down (MI:0096)
MINT-7966026: GABABR2 (uniprotkb:O88871) and Cav1.3 (uniprotkb:P27732) colocalize (MI:0403) by
ﬂuorescence microscopy (MI:0416)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Voltage-gated Ca2+ channels (VGCCs) control numerous cellular
responses such as muscle contraction, neurotransmission and gene
expression. VGCCs can be distinguished by their electrophysiolog-
ical properties: high-voltage-activated L-, N-, P/Q-, and R-type Ca2+
channels and low-voltage-activated T-type Ca2+ channels [1].
Among them, L-type Ca2+ channels, also known as CaV1 family,
comprise CaV1.1, CaV1.2, CaV1.3 and CaV1.4. In particular, CaV1.2
and CaV1.3 are widely expressed in neurons, where the both are
found in cell bodies and proximal dendrites [2,3]. However, their
biophysical and pharmacological properties are different [4].chemical Societies. Published by E
Division, Korea Institute of
ng, Sungbuk-gu, Seoul 136-CaV1.3 is activated at more hyperpolarized membrane potentials
and less sensitive to dihydropyridines than CaV1.2. While CaV1.2
has been extensively studied [5–8], the neuronal functions of
CaV1.3 are poorly understood.
To investigate the functions of CaV1.3 in the central nervous
system (CNS), we employed a yeast two-hybrid screening in the
rat brain cDNA library with the N-terminus of rat CaV1.3 a1 subunit
(CaV1.3-NT) as bait, and found the C-terminus of c-aminobutyric
acid (GABA) type B receptor subunit 2 (GABABR2) as a binding part-
ner. As a member of Gai/o family, it has been well known that acti-
vation of GABABR causes inhibition of N- and P/Q-type Ca2+
channels and subsequent suppression of neurotransmitter release
[9]. Besides these prominent inhibitory effects, activation of GA-
BABR has also been shown to augment L-type Ca2+ channels in var-
ious neurons [10,11].
In the present study, we demonstrated a physical interaction
between CaV1.3 a1 subunit and GABABR2 subunit using various
methods and further showed that activation of GABABR inducedlsevier B.V. All rights reserved.
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with CaV1.3 using whole-cell patch-clamp and intracellular Ca2+
imaging techniques.2. Materials and methods
2.1. Yeast two-hybrid assay
To construct bait, a cDNA fragment encoding CaV1.3-NT (ami-
no acids 1–151) was subcloned into the NdeI/SalI site of the GAL4
DNA-binding domain vector, pGBKT7. Bait plasmid was then
transformed into the yeast strain AH109. The rat brain cDNA li-
brary in the GAL4 activation domain vector, pACT2 (prey) was
transformed into the yeast strain Y187. The yeast two-hybrid as-
say was performed as described previously [12].
2.2. GST pull-down assay
GST pull-down assays were performed with puriﬁed GST and
GST-CaV1.3-NT proteins using the ProFound Pull-Down GST Pro-
tein–Protein Interaction Kit (Pierce, Rockford, IL). The immobilized
GST or GST-CaV1.3-NT proteins were incubated with cell lysates
prepared from HA-GABABR2-expressed HEK293 cells or rat brain.
Glutathione-bound proteins were eluted by boiling at 95 C in
SDS-sample buffer for 10 min, and detected by immunoblotting
with anti-GST (1:5000; Novagen, Madison, WI), anti-HA (1:1000;
Cell Signaling, Beverly, MA) and anti-GABABR2 (1:1000; Chemicon,
Temecula, CA) antibodies.2.3. Co-immunoprecipitation assay
Co-immunoprecipitation assays were performed using the Pro-
Found Mammalian Co-Immunoprecipitation Kit (Pierce). Brieﬂy,
lysates from adult rat hippocampi were precleared, and immuno-
precipitated with 10 lg of a speciﬁc antibody and 50 ll of Amino-
Link Plus Coupling Gel at 4 C for 6 h or overnight, and washed
ﬁve times. Immune complexes were eluted using IgG Elution Buf-
fer (Pierce) or by boiling at 95 C in SDS-sample buffer for 10 min,
and detected by immunoblotting with anti-CaV1.3 (1:200) or anti-
GABABR2 (1:1000) antibodies.2.4. Immunocytochemistry
For immunocytochemistry, cells were ﬁxed in 4% paraformalde-
hyde, and permeablized with 0.2% Triton X-100. After blocked with
3% bovine serum albumin, cells were incubated with rabbit anti-
CaV1.3 and guinea pig anti-GABABR2 antibodies, and then with
FITC- and rhodamine-conjugated secondary antibodies, respec-
tively. Cells were then mounted on a glass slide, and viewed on a
confocal FV 1000 laser scanning microscope (Olympus, Tokyo,
Japan).2.5. Electrophysiological recording
CaV1.3 currents were measured using Ba2+ as a charge carrier
with standard whole-cell patch-clamp techniques. Borosilicate
glass electrodes were ﬁlled with the internal solution containing
(in mM): 135 CsCl, 10 EGTA, 4 MgCl2, 10 HEPES and 4 Mg-ATP
(pH 7.4). The external solution contained (in mM): 135 CholineCl,
5 BaCl2, 1 MgCl2, 10 glucose and 10 HEPES (pH 7.4). Cells were held
at a holding potential of 80 mV, and currents were elicited by a
depolarizing test step to 10 mV for 200 ms. All the data were ob-
tained and analyzed using an EPC-10 ampliﬁer and Pulse/Pulseﬁt
software program (HEKA, Germany).2.6. Hippocampal neuron cultures, transfection and intracellular Ca2+
imaging
Hippocampal neuron cultures, transfection with small inter-
fering RNA (siRNA), and fura-2-based intracellular Ca2+ imaging
were carried out using the protocols from Kim et al. [12]. Hippo-
campi were isolated from 16 to 18-day old fetal Sprague–Dawley
rats, and hippocampal neurons were cultured and transfected
with siRNA after 5 days in vitro. Each siRNA at 5 pmol/ll con-
centration was transfected into the primary cultured rat hippo-
campal neurons using Lipofectamine 2000 (Invitrogen, Carlsbad,
CA).3. Results
3.1. Identiﬁcation of GABABR2 as a CaV1.3 binding protein using the
yeast two-hybrid system
To elucidate the function of CaV1.3 L-type Ca2+ channels and its
cellular mechanism in the CNS, we performed a yeast two-hybrid
screening using CaV1.3-NT. Through the screening of the rat brain
cDNA library, we found that GABABR2 interacts with CaV1.3-NT. To
conﬁrm this speciﬁc interaction, we carried out a yeast two-hybrid
assay using CaV1.3-NT cDNA (bait, amino acids 1–151) trans-
formed into the AH109 yeast strain and the C-terminus of GA-
BABR2 (GABABR2-CT) cDNA (prey, amino acids 741–941)
transformed into the Y187 yeast strain. When AH109 and Y187
yeast strains were mated, a blue color was detected by the b-galac-
tosidase colony-lift ﬁlter assay as shown in Fig. 1A. This result sug-
gests that the observed interaction between CaV1.3-NT and
GABABR2-CT is positive.
3.2. In vitro and in vivo interaction between CaV1.3 and GABABR2
Next, we attempted to determine whether the association of
CaV1.3 and GABABR2 occurs in native cells. As shown in Fig. 1B,
GST-CaV1.3-NT interacts with HA-tagged GABABR2 (HA-GABABR2)
in HEK293 cells while GST, a negative control, alone was shown
not to interact with HA-GABABR2. Subsequently, we conﬁrmed
the association of CaV1.3 and GABABR2 in adult rat brain lysates.
GST-CaV1.3-NT interacts with endogenous GABABR2 in rat brain ly-
sates (Fig. 1C). Although these results suggest an interaction be-
tween CaV1.3-NT and GABABR2, it is necessary to demonstrate
the association between endogenous CaV1.3 and GABABR2 in na-
tive tissues. We therefore examined further to see whether
CaV1.3 binds to GABABR2 in adult rat hippocampus using an
in vivo co-immunoprecipitation assay. Cell lysates prepared from
adult rat hippocampi were immunoprecipitated with anti-CaV1.3
antibodies, and subsequently immunoblotted with anti-GABABR2
antibodies. In Fig. 1D, GABABR selectively binds to endogenous
CaV1.3 in rat hippocampi whereas no signal was detected in an
IgG control. When co-immunoprecipitation was performed in re-
verse with anti-GABABR2 antibodies followed by immunoblotting
with anti-CaV1.3, the result was the same (Fig. 1E). These results
strongly suggest that a speciﬁc interaction between CaV1.3 and GA-
BABR2 occurs in mammalian cells as well as rat brain, especially in
the hippocampus.3.3. Cellular localization and functional interaction of CaV1.3 with
GABABR2 in HEK293 cells
For a functional interaction between the two proteins, CaV1.3
and GABABR, they must be positioned in close proximity. We there-
fore tested whether the both proteins are localized in the same
subcellular compartment in heterologously expressed HEK293
Fig. 1. Physical interaction between CaV1.3 and GABABR2. (A) Results from b-galactosidase colony-lift ﬁlter assay. (B and C) Selective binding between CaV1.3-NT and
GABABR2 using a GST pull-down assay. (D and E) In vivo co-immunoprecipitation assay using hippocampal lysates (Hippo). The experiments shown in Fig. 1B–E were
repeated in triplicate, showing the same results.
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and GABABR2 were immunostained with anti-CaV1.3 and then with
FITC-conjugated secondary antibodies for CaV1.3, and immuno-
stained with anti-GABABR2 and then with rhodamine-conjugated
secondary antibodies for GABABR. Immunoﬂuorescence analysis
revealed that CaV1.3 was predominantly localized on plasmamem-
brane, and co-localized with GABABR as shown in the merged im-
age of Fig. 2A. Based on the evidence for a physical interaction
between CaV1.3 and GABABR2, we examined whether the activa-
tion of GABABR functionally modulates CaV1.3 activity. HEK293
cells transfected with CaV1.3 a1 and b3 subunits and GABABR1a
and GABABR2 subunits were used for whole-cell patch-clamp
recordings. The transfection efﬁciency was indirectly conﬁrmed
using co-transfected GFP. Ba2+ currents via CaV1.3 were increased
when a selective GABABR agonist, baclofen, was applied. In 70%
of GFP-positive and current-recordable cells, we observed baclo-
fen-mediated increase in Ba2+ currents. In Fig. 2B, a representative
trace of the CaV1.3 recordings shows a rapid increase in Ba2+
currents upon the application of 100 lM baclofen. Baclofen signif-icantly increased peak currents of CaV1.3 (156.9 ± 9.4% of control,
n = 4, Fig. 2C), but did not cause any shift in a current–voltage
curve in Fig. 2D (n = 3). These data provide the ﬁrst experimental
evidence showing that activation of GABABR increases CaV1.3 L-
type Ca2+ currents in HEK293 cells.
3.4. Cellular localization and functional interaction of CaV1.3 with
GABABR2 in cultured hippocampal neurons
We next examined whether co-localization and functional
interaction of CaV1.3 with GABABR2 also occur in neurons. CaV1.3
and GABABR2 were immunostained in cultured rat hippocampal
neurons using the same antibodies as used in HEK293 cells. As
shown in Fig. 3A, CaV1.3 was localized on plasma membrane of
the cell body as well as dendrites, and co-localized with GABABR2.
The double-labeling experiments suggested co-localization of
CaV1.3 and GABABR2 in hippocampal neurons. To study further
the functional interaction, we tested the effect of baclofen on
high-K-induced intracellular Ca2+ increase using fura-2-based
Fig. 2. Cellular localization and functional interaction between CaV1.3 and GABABR in HEK293 cells. (A) Confocal microscope-based immunoﬂuorescence analysis. Negative
controls (bottom) were performed with CaV1.3 peptide, FITC- or rhodamine-conjugated IgG secondary antibodies only. (B) Representative time course of peak Ba2+ currents
(Ipeak) showing baclofen-induced increase in Ba2+ currents. (C) Pooled results illustrating the mean value of baclofen-induced increment. Each value was normalized as
relative percentage of the control current before drug application (***P < 0.001). (D) Mean current–voltage relationships of Ba2+ current density (I) in the absence (open
circles) or presence (ﬁlled circles) of 100 lM baclofen.
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depolarized by a brief application (10 s) of 60 mM KCl, and N- and
P/Q-type Ca2+ currents were blocked by co-application of N-type
Ca2+ channel blocker, x-conotoxin MVIIA (1 lM), and P/Q-type
Ca2+ channel blocker, x-agatoxin IVA (100 nM). Under these condi-
tions, 100 lM baclofen augmented high-K-induced intracellular
Ca2+ increase by 32.4 ± 7.5% (n = 5, Fig. 3B).
Because there are two types of L-type Ca2+ channels in neurons,
we further attempted to identify a speciﬁc role of CaV1.3 using a
siRNA-mediated silencing method in cultured hippocampal
neurons. Selective knockdown of CaV1.2 or CaV1.3 with siRNA
was proven in our previous study [12]. Brieﬂy, CaV1.2- and
CaV1.3-siRNA decreased CaV1.2 and CaV1.3 mRNA, respectively
without affecting the gene expression of the other channel. Using
the CaV1.2 or CaV1.3 knockdown cells, the effect of baclofen on
the high-K-induced intracellular Ca2+ increase was studied. In
Fig. 3C, baclofen had no effect in CaV1.3 knockdown cells (n = 6).
On the other hand, augmentation in the high-K-induced intracellu-
lar Ca2+ increase was still observed upon baclofen application in
CaV1.2 knockdown cells (32.3 ± 12.2%, n = 4, Fig. 3D). Fig. 3E illus-
trated the pooled data from CaV1.2- or CaV1.3-siRNA-treated cells
as well as scrambled siRNA-treated cells as a control. These results
clearly support a speciﬁc role of CaV1.3 in GABABR-mediated facil-
itation of L-type Ca2+ currents both in HEK293 cells and in hippo-
campal neurons.
4. Discussion
In the present study, we ﬁrst identiﬁed a direct interaction
between CaV1.3 and GABABR2, and further examined functional
modulation of CaV1.3 activity by GABABR in a heterologouslyexpressed system as well as in cultured hippocampal neurons.
Here, we report the three principal ﬁndings on a physical and
functional interaction between CaV1.3 and GABABR2: ﬁrst, the
present study is an original report that demonstrates the forma-
tion of the CaV1.3/GABABR2 protein complex. We initially em-
ployed a yeast two-hybrid screening in the rat brain cDNA
library with CaV1.3-NT cDNA, and found GABABR2-CT as a binding
partner. This speciﬁc interaction was further conﬁrmed using a
yeast two-hybrid assay, a GST pull-down assay, co-immunopre-
cipitation, and cellular localization in HEK293 cells, and also in
rat hippocampal neurons. Secondly, the present work is the ﬁrst
report showing the facilitative effect of baclofen on CaV1.3 cur-
rents through GABABR. It has been known that the activation of
GABABR augments L-type Ca2+ channel currents in various neu-
rons [10,11]. However, this phenomenon is hard to be observed
in the CNS because inhibition of N- and P/Q-type Ca2+ channels
by GABABR is dominant [9]. Based on the evidences for a physical
association and cellular localization of CaV1.3 with GABABR2, we
further examined a functional coupling between the two proteins,
and found that the activation of GABABR increases CaV1.3 currents
without modulating either channel kinetics or voltage depen-
dency. Further experiments using the CaV1.2 expressing cell line
would be interesting to carry out to see whether GABABR has
the effects on CaV1.2. The third and the last piece of novel discov-
eries in the present work is functional modulation of CaV1.3 activ-
ity by GABABR in cultured rat hippocampal neurons. Although
CaV1.3 is activated at more hyperpolarized potentials and less
sensitive to dihydropyridines than CaV1.2 [4], these differences
are not big enough to distinguish a speciﬁc role of each channel,
especially in hippocampal neurons where the both CaV1.2 and
CaV1.3 are expressed. In the present study, we observed baclo-
Fig. 3. Cellular localization and functional interaction between CaV1.3 and GABABR in cultured hippocampal neurons. (A) Confocal microscope-based immunoﬂuorescence
analysis. (B–D) 60 mM KCl (high-K)-induced intracellular Ca2+ increases were measured in negative siRNA- (control, B), CaV1.3 siRNA- (C), and CaV1.2 siRNA- (D) treated
neurons in the presence of 1 lM x-conotoxin MVIIA and 100 nM x-agatoxin IVA as indicated with bold lines. (E) Bar graphs show the pooled results illustrating the changes
of 340/380 ratio at each indicated (#) peak value. Each value was normalized as relative percentage of the control value before baclofen (Bcf) application (**P < 0.01; *P < 0.05;
NS, not signiﬁcant).
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down cells, but not in CaV1.3 knockdown cells in the presence
of N- and P/Q-type Ca2+ channel blockers, which suggests that in-
crease in L-type Ca2+ channel currents by baclofen is dependent
on CaV1.3, but not on CaV1.2. Under our experimental conditions,
however, R-type Ca2+ currents were unblocked, which may ex-
plain the smaller facilitative effect of baclofen in hippocampal
neurons than that in HEK293 cells. To conﬁrm the role of GABABR
on CaV1.3 activation, whole-cell patch-clamp recordings are being
undertaken in the presence of blocker cocktails that inhibit all
non-L-type Ca2+ channels including R-type Ca2+ channels.
In the CNS, neuronal L-type Ca2+ channels are particularly
important due to their roles in translating synaptic activity into
gene expression and neuronal function [5–8]. Recent studies have
suggested the roles of CaV1.2 in synaptic plasticity and modulation
of gene expression-related factors, and have also proposed the de-
tailed mechanism of CaV1.2-mediated gene expression [7,8]. On
the contrary, the roles of neuronal CaV1.3 are only beginning tobe investigated. Our results therefore would provide an evidence
for potential roles of CaV1.3 in neuronal activities and synaptic
plasticity via a novel linkage with GABABR in the hippocampus.
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